Indolyl derivatives as liver-x-receptor (LXR) modulators

摘要

The invention relates to compounds of formula (I): and pharmaceutically acceptable salts and pharmaceutically acceptable esters thereof, wherein R¹, R², R³, R⁴, R⁵, R⁶, A, m, n and p are defined as in claim 1 . These compounds can be used as pharmaceutical compositions for the treatment of, for example, diabetes.